Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

387
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
387
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

147
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
147
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

331
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
331
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

310
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

531
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.

Oncogene·2026
Same author

Obesity-associated carcinogenesis with treatment gaps: A narrative review of updated evidence and natural products strategies.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same author

Corrigendum to "Exogenous glucocorticoids upregulate preference for sweet in sand rat, Psammomys obesus" [Eur. J. Pharmacol. pp 1-8, vol: 1018, 178688].

European journal of pharmacology·2026
Same author

A Comparative Study of the Clinical Efficacy of Superselective Adrenal Artery Embolization for Patients with Primary Aldosteronism.

American journal of hypertension·2025
Same author

Potent inhibition of human and rat 17β-hydroxysteroid dehydrogenase 1 by curcuminoids and the metabolites: 3D QSAR and in silico docking analysis.

SAR and QSAR in environmental research·2024
Same author

An impactful prospective study on pulmonary tuberculosis in geriatric populations besides its clinical outcomes and implications in the Indian subcontinent.

European review for medical and pharmacological sciences·2024

Related Experiment Video

Updated: Mar 22, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Ethno-Cultural Considerations in Cardiac Patients' Medication Adherence.

K M King-Shier1, S Singh1, N A Khan2

  • 11 University of Calgary, Alberta, Canada.

Clinical Nursing Research
|April 29, 2016
PubMed
Summary

Understanding cardiac medication adherence requires recognizing cultural motivations. Factors like family, faith, and physician communication significantly impact adherence across diverse patient groups.

Keywords:
cardiovascular diseasesclinical researchcommunity-based carequalitative methods

Related Experiment Videos

Last Updated: Mar 22, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

Area of Science:

  • Cardiology
  • Medical Sociology
  • Health Psychology

Background:

  • Cardiac medication adherence is crucial for patient outcomes.
  • Understanding cultural influences on adherence is vital for effective treatment.

Purpose of the Study:

  • To explore factors influencing cardiac medication adherence in South Asian, Chinese, and European White patients.
  • To identify ethno-culturally specific motivators and deterrents to medication adherence.

Main Methods:

  • Purposive sampling of 64 cardiac patients from an existing study cohort.
  • Qualitative analysis of audio-recorded interviews to identify themes.
  • Exploration of cultural factors impacting medication adherence.

Main Results:

  • Physician communication and desire for a longer, symptom-free life improved adherence.
  • Motivations varied: European Whites focused on well-being, South Asians on faith/family, Chinese on avoiding illness and obeying providers.
  • Family support, positive experiences, and routine also facilitated adherence.

Conclusions:

  • Adherence is influenced by a complex interplay of cultural values, personal beliefs, and healthcare interactions.
  • Developing ethno-culturally tailored interventions is essential for optimizing cardiac medication adherence.
  • Deterrents to adherence are often the inverse of identified motivators.